ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs MXN
16.88185
-0.02%
Brent Oil
83.345
-0.16%
Bitcoin
63,439.00
0.43%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)

  7. Enanta Pharmaceuticals Inc (ENTA) Noticias

ENTA Enanta Pharmaceuticals Inc

14.60
-0.57 (-3.76%)
06 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Enanta Pharmaceuticals Inc ENTA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.57 -3.76% 14.60 18:35:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
15.22 14.42 15.395 14.60 15.17
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
06/5/202415:05EDGAR2Form 8-K - Current report
06/5/202415:01BWEnanta Pharmaceuticals Reports Financial Results for its..
30/4/202406:10BWEnanta Pharmaceuticals Announces Inducement Grants Under..
30/4/202406:00BWEnanta Pharmaceuticals Announces the Appointment of Matthew..
29/4/202406:00BWEnanta Pharmaceuticals to Host Conference Call on May 6 at..
17/4/202406:00BWEnanta Pharmaceuticals Announces Data Presentation at ESCMID..
08/3/202416:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202416:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202406:00BWEnanta Pharmaceuticals to Participate at Leerink Partners..
27/2/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202412:11EDGAR2Form SCHEDULE 13G - Statement of acquisition of beneficial..
14/2/202419:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:26EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202415:05EDGAR2Form 8-K - Current report
07/2/202415:01BWEnanta Pharmaceuticals Reports Financial Results for its..
06/2/202406:00BWEnanta Pharmaceuticals to Participate at the Oppenheimer..
31/1/202406:00BWEnanta Pharmaceuticals to Host Conference Call on February 7..
26/1/202415:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
26/1/202415:25EDGAR2Form DEF 14A - Other definitive proxy statements
24/1/202416:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/1/202415:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202406:00BWEnanta Pharmaceuticals to Provide Updates on its Research..
03/1/202406:00BWEnanta Pharmaceuticals to Present at the 42nd Annual J.P...
26/12/202315:06EDGAR2Form 8-K - Current report
15/12/202319:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202316:16EDGAR2Form 144 - Report of proposed sale of securities
06/12/202319:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202319:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202319:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202319:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202319:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202319:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/12/202319:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202320:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ENTA
Enanta Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados